Obesity is a growing global health challenge ... ESG had a favorable safety profile; 20% of patients experienced mild abdominal pain, constipation, heartburn, and nausea after the procedure that ...

Obesity, Leptin Resistance, and Metabolic Syndrome MS, defined by a constellation of high blood pressure, elevated ...

So what is semaglutide and who uses it in India? Semaglutide belongs to the class of drugs called Glucagon-like peptide-1 ...

This study demonstrates that global or adipose tissue-specific knockout of CIDEC/FSP27 significantly reduces AAA incidence ...

A study published in the American Journal of Obstetrics and Gynecology demonstrates that when the diabetes drug metformin is ...

it’s not just about reducing the size of the stomach but also about how it impacts hormonal and metabolic functions. So, how ...

Obesity, especially abdominal obesity, is central to the metabolic syndrome and is strongly related to polycystic ovary syndrome (PCOS) in women. Obese women are particularly susceptible to ...

The Epitomee capsule -- which was cleared by the FDA in September for weight management -- is a novel shape-shifting device ...

A Norwegian man, Thomas Kraut, was wrongly diagnosed with obesity and prescribed Ozempic for 12 years, while a 60-pound ...

High cholesterol management tips: 5 empty stomach drinks to clear clogged arteries, naturally and prevent heart diseases.

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.